Our in vitro and in vivo results demonstrate that curcumin inhibits the cell growth of bladder cancer at least partially through inhibiting Hippo pathway effectors YAP/TAZ, which induce the accelerated degradation of KLF5 protein and subsequently cause the downregulation of cyclin D1. Here, KLF5 is linked to urinary bladder carcinoma.